LeydenJMChongWKKleinigTLeeAFieldJBJannesJ. A population-based study of thrombolysis for acute stroke in South Australia. Med J Aust2011; 194: 111–5.
2.
AdeoyeOHornungRKhatriPKleindorferD. Recombinant tissue-type plasminogen activator use for ischemic stroke in the United States: A doubling of treatment rates over the course of 5 years. Stroke2011; 42: 1952–5.
3.
BryerAWassermanS. Thrombolysis for acute ischemic stroke in South Africa. Int J Stroke2013; 8(Suppl. A100): 112–3.
4.
SingerOHamannGMisselwitzBSteinmetzHFoerchC. Time trends in systemic thrombolysis in a large hospital-based stroke registry. Cerebrovasc Dis2012; 33: 316–21.